A importância da atenção farmacêutica na adesão a terapia antirretroviral no HIV/AIDS

Abstract

With chronicity of AIDS and the increasing number of patients on Antiretroviral Therapy (ART) monitoring of adherence to treatment has become a priority in public health, for maintenance of high rates of adherence depends on the success of treatment. In front of a situation of chronic disease, challenges arise, determining the need for new practices related to adherence monitoring of People Living with HIV/AIDS (PLWHA) and before this context, the Pharmaceutical Care presents itself as an instrument to improve adherence to TARV, since studies show that the Pharmaceutical Care is able to improve adherence. So, the objective was to evaluate the influence of Pharmaceutical Care on adherence to antiretrovirals in PVHA starting treatment in a Dispenser Unit Antiretroviral Drugs (UDM). The longitudinal study has been realized with convenience sampling where included patients starting TARV in naïve patients, were divided into two study groups. The intervention group received Pharmaceutical care and monitoring, while the control group followed the routine care of the service. Adherence to treatment was confirmed by self-report, regular withdrawals of ARV and evolution of viral load. The profile of PLHA included in this study presented social demographic characteristics that follow the national epidemiological trends. Adherence to antiretroviral therapy showed better results in the intervention group. It was found that the highest number of dropouts in the control group occurred when patients given medical follow-up in public health services compared with individuals. The results of the study allowed the development of a protocol for application in Pharmaceutical care routine UDM.